Titan Pharmaceuticals
TTNP
#10416
Rank
NZ$10.5 M
Marketcap
NZ$7.90
Share price
-3.76%
Change (1 day)
37.72%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -NZ$4.73 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$8.06 Million, an increase over its 2023 earnings that were of -NZ$9.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$4.73 Million-41.35%
2024 -NZ$8.06 Million-15.5%
2023 -NZ$9.54 Million-45.43%
2022 -NZ$17.48 Million16.29%
2021 -NZ$15.04 Million-907.36%
2020 NZ$1.86 M-106.6%
2019 -NZ$28.19 Million82.4%
2018 -NZ$15.46 Million-36.93%
2017 -NZ$24.51 Million-378.62%
2016 NZ$8.79 M-145.53%
2015 -NZ$19.32 Million369.37%
2014 -NZ$4.12 Million-125.9%
2013 NZ$15.89 M-177.74%
2012 -NZ$20.44 Million13.59%
2011 -NZ$18 Million74.37%
2010 -NZ$10.32 Million3.61%
2009 -NZ$9.96 Million
2007 -NZ$31.58 Million12.08%
2006 -NZ$28.17 Million-28.65%
2005 -NZ$39.48 Million-10.03%
2004 -NZ$43.89 Million-6.08%
2003 -NZ$46.73 Million-14.76%
2002 -NZ$54.82 Million32.52%
2001 -NZ$41.37 Million27.55%
2000 -NZ$32.43 Million62.5%
1999 -NZ$19.96 Million4.04%
1998 -NZ$19.19 Million49.33%
1997 -NZ$12.85 Million-27.88%
1996 -NZ$17.82 Million13.04%
1995 -NZ$15.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-NZ$0.21 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$20.57 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.44 Billion 9,035.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.48 B-1,155,037.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.12 B-585,447.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
NZ$44.77 M-1,031.98%๐Ÿ‡บ๐Ÿ‡ธ USA